Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • The 2016 Small-Cap Biotech Watchlist Debuts at the Biotech Showcase - IT Business Net
    The Life Sciences Report's 2016 Small-Cap Biotech Watchlist - Freshnews.com
    01/28/2016 - 4:10 am | View Link
  • More
BING NEWS:
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 7:04 pm | View Link
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/18/2013 - 7:00 pm | View Link
  • AstraZeneca could buy Bristol stake in diabetes JV: analyst
    LONDON (Reuters) - AstraZeneca may seek to increase its stake in a diabetes joint venture with Bristol-Myers Squibb, following a decision by the U.S. firm to exit diabetes drug research, according to Citi. Bristol said on Thursday it would no longer ...
    11/8/2013 - 5:38 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    NEW YORK (AP) -- Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments. After the deal is complete, Bristol-Myers will ...
    07/2/2012 - 1:21 pm | View Link
  • Bristol-Myers, AZ aim for diabetes glory with Amylin buy
    Now that Bristol-Myers Squibb ($BMY) and AstraZeneca ($AZN) have teamed up to buy Amylin Pharmaceuticals ($AMLN), the ... AstraZeneca will pay Bristol-Myers $3.4 billion for beefing up their current diabetes-drug alliance. Obviously, Astra and Bristol ...
    07/2/2012 - 4:27 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer. Including Amylin's debt and a ...
    07/1/2012 - 6:42 am | View Link
  • Bristol-Myers to acquire diabetes drug maker Amylin
    Amylin Pharmaceuticals Inc., the San Diego drug maker whose treatments include the diabetes therapies Bydureon and Byetta, will be acquired by Bristol-Myers Squibb Co. for $5.3 billion in cash. Bristol-Myers agreed to pay $31 a share for Amylin ...
    06/29/2012 - 8:54 pm | View Link
  • More
BING SEARCH:
  • Bristol-Myers to buy diabetes drug maker for $5B
    From Yahoo Finance: Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the ...
    07/1/2012 - 1:07 pm | View Website
  • Bristol Will Buy Diabetes Drug Maker
    Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people ...
    01/21/2016 - 6:36 am | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    From Yahoo Finance: Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the ...
    07/1/2012 - 1:07 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash.
    07/1/2012 - 1:36 pm | View Website
  • Bristol-Myers To Buy Diabetes Drug Maker For $5B
    NEW YORK (AP) — Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among ...
    01/24/2016 - 2:51 am | View Website
  • Bristol Will Buy Diabetes Drug Maker
    Bristol Will Buy Diabetes Drug Maker WSJ June 30, 2012 By JONATHAN ROCKOFF Bristol-Myers Squibb Co. BMY +2.48% will buy diabetes drug maker Amylin Inc. in a $7 ...
    01/23/2016 - 9:11 am | View Website
  • Bristol Will Buy Diabetes Drug Maker
    Industry News: The latest product information direct from the source – manufacturers and suppliers.
    | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News